For instance, a study revealed that LMP1 conferred drug resistance of T-cell lymphoma cell lines in response to doxorubicin by upregulating the expression of SNF1/AMP kinase-related kinase, which subsequently increased the expression of anti-apoptotic factors, BCL6 and BIRC2 [43]. Here, PDLIM7 is linked to T-cell non-Hodgkin lymphoma.